Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. National Taiwan University Hospital / 醫學院附設醫院 (臺大醫院)
  4. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II
 
  • Details

Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II

Journal
Atherosclerosis
Journal Volume
266
Pages
158-166
Date Issued
2017
Author(s)
Gitt A.K.
Lautsch D.
Ferri?res J.
De Ferrari G.M.
Vyas A.
Baxter C.A.
Bash L.D.
Ashton V.
Horack M.
Almahmeed W.
FU-TIEN CHIANG  
Poh K.K.
Brudi P.
Ambegaonkar B.
DOI
10.1016/j.atherosclerosis.2017.08.013
URI
https://scholars.lib.ntu.edu.tw/handle/123456789/551631
Abstract
Background and aims Low-density lipoprotein cholesterol (LDL-C) is a major contributor to cardiovascular disease. In the Dyslipidemia International Study II (DYSIS II), we determined LDL-C target value attainment, use of lipid-lowering therapy (LLT), and cardiovascular outcomes in patients with stable coronary heart disease (CHD) and those suffering from an acute coronary syndrome (ACS). Methods DYSIS II included patients from 18 countries. Patients with either stable CHD or an ACS were enrolled if they were ?18 years old and had a full lipid profile available. Data were collected at a physician visit (CHD cohort) or at hospital admission and 120 days later (ACS cohort). Results A total of 10,661 patients were enrolled, 6794 with stable CHD and 3867 with an ACS. Mean LDL-C levels were low at 88 mg/dl and 108 mg/dl for the CHD and ACS cohorts respectively, with only 29.4% and 18.9% displaying a level below 70 mg/dl. LLT was utilized by 93.8% of the CHD cohort, with a mean daily statin dosage of 25 ± 18 mg. The proportion of the ACS cohort treated with LLT rose from 65.2% at admission to 95.6% at follow-up. LLT-treated patients, who were female, obese, or current smokers, were less likely to achieve an LDL-C level of <70 mg/dl, while those with type 2 diabetes, chronic kidney disease, or those taking a higher statin dosage were more likely. Conclusions Few of these very high-risk patients achieved the LDL-C target, indicating huge potential for improving cardiovascular outcome by use of more intensive LLT. ? 2017
Subjects
Acute coronary syndrome; Cholesterol; Coronary heart disease; Dyslipidemias; Hydroxymethylglutaryl-CoA reductase inhibitors; LDL; Myocardial infarction; Unstable angina
SDGs

[SDGs]SDG3

Other Subjects
atorvastatin; ezetimibe; low density lipoprotein cholesterol; rosuvastatin; simvastatin; antilipemic agent; biological marker; hydroxymethylglutaryl coenzyme A reductase inhibitor; low density lipoprotein cholesterol; acute coronary syndrome; adult; aged; Article; cholesterol blood level; chronic kidney failure; cohort analysis; controlled study; female; gender; high risk patient; hospital admission; hospital readmission; human; intermediate risk patient; ischemic heart disease; low risk patient; major clinical study; male; non insulin dependent diabetes mellitus; obesity; observational study; priority journal; prospective study; sedentary lifestyle; smoking; stable angina pectoris; acute coronary syndrome; Asia; blood; clinical trial; combination drug therapy; comorbidity; coronary artery disease; dyslipidemia; Europe; lifestyle; middle aged; Middle East; multicenter study; risk factor; sex factor; time factor; treatment outcome; Acute Coronary Syndrome; Aged; Asia; Biomarkers; Cholesterol, LDL; Comorbidity; Coronary Disease; Drug Therapy, Combination; Dyslipidemias; Europe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Life Style; Male; Middle Aged; Middle East; Prospective Studies; Risk Factors; Sex Factors; Time Factors; Treatment Outcome
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science